Cargando…
Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome
INTRODUCTION AND HYPOTHESIS: Intravesically administered lidocaine is used in patients with bladder pain syndrome (BPS) to test the hypothesis that symptoms have a peripheral versus central mechanism. METHODS: A cross-sectional study of 24 female patients with BPS was performed. The Central Sensitis...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647211/ https://www.ncbi.nlm.nih.gov/pubmed/30874834 http://dx.doi.org/10.1007/s00192-019-03892-2 |
_version_ | 1783437681220386816 |
---|---|
author | Offiah, Ifeoma Dilloughery, Elaine McMahon, Stephen B. O’Reilly, Barry A. |
author_facet | Offiah, Ifeoma Dilloughery, Elaine McMahon, Stephen B. O’Reilly, Barry A. |
author_sort | Offiah, Ifeoma |
collection | PubMed |
description | INTRODUCTION AND HYPOTHESIS: Intravesically administered lidocaine is used in patients with bladder pain syndrome (BPS) to test the hypothesis that symptoms have a peripheral versus central mechanism. METHODS: A cross-sectional study of 24 female patients with BPS was performed. The Central Sensitisation Inventory (CSI) and Kings Health Questionnaire (KHQ) were completed. Urodynamic assessment was undertaken. Women were asked to report their pain using a numeric rating scale at cystometric capacity and post void. Participants then received an intravesical instillation of either 20 ml of 2% alkalinised lidocaine (n = 16) or 20 ml of normal saline (n = 8). These solutions were allowed to remain in situ for 20 min and pain score repeated. Urodynamics was repeated. RESULTS: There was a statistically significant volume increase following lidocaine treatment: maximal cystometric capacity (MCC) 192–261 ml post lidocaine (p = 0.005.) In contrast, there was no significant difference in the saline controls: MCC 190–183 ml (p = 0.879.) Individual analysis revealed five of 16 lidocaine participants did not respond to lidocaine. These five reported a significantly worse quality of life (QoL) than lidocaine responders and had a tendency towards central sensitivity syndromes. CONCLUSION: Lidocaine significantly improved MCC in 11/16 participants in this study. These patients appear to have peripherally mediated disease. However, the failure of response to treatment in five participants, as well as their tendency towards central sensitivity syndromes, implies that in this subgroup, a peripheral drive from the bladder is not critical to their pain, suggesting central nervous system (CNS) pathology. This simple and safe test could be used to stratify patients for research or therapeutic trials. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00192-019-03892-2) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6647211 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-66472112019-08-06 Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome Offiah, Ifeoma Dilloughery, Elaine McMahon, Stephen B. O’Reilly, Barry A. Int Urogynecol J Original Article INTRODUCTION AND HYPOTHESIS: Intravesically administered lidocaine is used in patients with bladder pain syndrome (BPS) to test the hypothesis that symptoms have a peripheral versus central mechanism. METHODS: A cross-sectional study of 24 female patients with BPS was performed. The Central Sensitisation Inventory (CSI) and Kings Health Questionnaire (KHQ) were completed. Urodynamic assessment was undertaken. Women were asked to report their pain using a numeric rating scale at cystometric capacity and post void. Participants then received an intravesical instillation of either 20 ml of 2% alkalinised lidocaine (n = 16) or 20 ml of normal saline (n = 8). These solutions were allowed to remain in situ for 20 min and pain score repeated. Urodynamics was repeated. RESULTS: There was a statistically significant volume increase following lidocaine treatment: maximal cystometric capacity (MCC) 192–261 ml post lidocaine (p = 0.005.) In contrast, there was no significant difference in the saline controls: MCC 190–183 ml (p = 0.879.) Individual analysis revealed five of 16 lidocaine participants did not respond to lidocaine. These five reported a significantly worse quality of life (QoL) than lidocaine responders and had a tendency towards central sensitivity syndromes. CONCLUSION: Lidocaine significantly improved MCC in 11/16 participants in this study. These patients appear to have peripherally mediated disease. However, the failure of response to treatment in five participants, as well as their tendency towards central sensitivity syndromes, implies that in this subgroup, a peripheral drive from the bladder is not critical to their pain, suggesting central nervous system (CNS) pathology. This simple and safe test could be used to stratify patients for research or therapeutic trials. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00192-019-03892-2) contains supplementary material, which is available to authorized users. Springer International Publishing 2019-03-14 2019 /pmc/articles/PMC6647211/ /pubmed/30874834 http://dx.doi.org/10.1007/s00192-019-03892-2 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Offiah, Ifeoma Dilloughery, Elaine McMahon, Stephen B. O’Reilly, Barry A. Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome |
title | Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome |
title_full | Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome |
title_fullStr | Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome |
title_full_unstemmed | Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome |
title_short | Prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome |
title_sort | prospective comparative study of the effects of lidocaine on urodynamic and sensory parameters in bladder pain syndrome |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647211/ https://www.ncbi.nlm.nih.gov/pubmed/30874834 http://dx.doi.org/10.1007/s00192-019-03892-2 |
work_keys_str_mv | AT offiahifeoma prospectivecomparativestudyoftheeffectsoflidocaineonurodynamicandsensoryparametersinbladderpainsyndrome AT dillougheryelaine prospectivecomparativestudyoftheeffectsoflidocaineonurodynamicandsensoryparametersinbladderpainsyndrome AT mcmahonstephenb prospectivecomparativestudyoftheeffectsoflidocaineonurodynamicandsensoryparametersinbladderpainsyndrome AT oreillybarrya prospectivecomparativestudyoftheeffectsoflidocaineonurodynamicandsensoryparametersinbladderpainsyndrome |